Global Optogenetics Market: Overview

The global optogenetics market size reached a significantly robust value in 2020 and is expected to register a notable CAGR over the forecast period.. Industry analysis indicates that demand for reliable products has been rising substantially, and its adoption across healthcare industry has been increasing in parallel due to changing market trends and consumption patterns, and these factors are expected to support market growth over the forecast period.

Optogenetics refers to a range of optical techniques used to elicit a physiological response in targeted biological systems in the absence of pharmacology and electric stimulations. Optogenetics controls neural activity by combining genetic engineering and optical tools and is widely used in neuroscience for modulation of neural circuits with a high degree of precision and specificity. The optogenetics market is segmented by light equipment, actuator, sensor, application, and geography.

Optogenetics is a new research method that has revolutionized neuroscience over the last few years and opened up new possibilities to develop a deeper understanding of how human brain functions.

In addition, it allows researchers to study how neurological activity patterns within specific brain cells give rise to thoughts, behaviors, and memories at an unprecedented precision level. Thus, it helps to find cures and treatments for neurological and psychiatric disorders, such as depression, addiction, schizophrenia, and Parkinson\'s disease.

Global Optogenetics Market: Dynamics
Drivers:

Major factors driving the growth of the market include growing scope of optogenetics as a potential diagnostic tool in the field of neurosciences, rapid growth of advanced technologies, and increasing use of multimodal imaging.

Improvement and technological advancements in toolsets, such as neural connectivity, cell phenotyping tools, neural recording, and imaging tools, have further enhanced and helped the growth of the optogenetics market in neuroscience.

Optogenetics is widely used to treat neurological disorders such as depression. Depression is caused by chronic stress that causes a series of negative memories. Optogenetics technology is used to place genes that express light-sensitive proteins into mammalian cells, which normally lack such proteins. When the proteins are illuminated with specific wavelengths of light, they change the behavior of the cells, thereby introducing certain types of ions or pushing out a few to alter electrical activity. On the other hand, optogenetics is used in treatment of retinal diseases and hearing impairment. Advancements in optogenetics technology has led to a sound understanding of neuroscience.

Furthermore, rampant advancements in technologies, such as ultrafast laser tools, LEDs, and ytterbium-based lasers, are other factors driving the growth of optogenetics market.

Restraints:

Significant factors including excessive cost of technology, dearth of skilled professionals, lack of awareness among people in various developing as well as developed economies, and difficulty in coupling light with a Fiber Optic Cable may hinder growth of the optogenetics market to a certain extent during the forecast period. In addition, strong dynamics of conventional procedures performed by healthcare professionals, lack of availability of genetic reagents used for probing biological processes, and variable price of raw materials will further act as a challenge for market growth.

Market Insights:
Light Equipment Outlook:

On the basis of light equipment, the market is segmented into laser, light-emitting diode (LED), and others. The LED segment will lead other segments during the forecasted period due to cost affordability, relatively smaller size, reliability, and ease of control. Rising incorporation into implants for untethered light delivery and increasing need for efficient technology will also propel segment growth.

Application Outlook:

Based on application, the market is bifurcated into retinal disease treatment, cardiovascular ailments, neuroscience, behavioural tracking, and pacing. Growing usage for studying the underlying factors in case of depression, anxiety, addictions, and mood disorders will boost revenue growth of the behavioural tracking segment. The neuroscience segment will also lead at a significant rate owing to rising prevalence of Epilepsy, Alzheimer’s, Parkinson’s, other and memory disorders.

Global Optogenetics Market: Regional Landscape

North America is expected to account for largest share of the optogenetics market during the forecast period owing to rising prevalence of cardiovascular and neural disorders, favorable healthcare support, advanced infrastructure, and well-established medical research industry for development of innovative devices. On the other hand, the market in Asia Pacific will register highest CAGR due to rising geriatric population, major reimbursement policies, increasing government regulatory approvals and presence of a large consumer base coupled with substantial investments from public and private organizations for R&D expenditure.

Major Players in the Global Optogenetics Market

Addgene, Cobolt Inc., Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, Scientifica, Shanghai Laser & Optics Century Co. Ltd, and Thorlabs Inc., Thorlabs, Inc. Laserglow Technologies, Regenxbio, Inc., UPenn Vector Core, and Jackson Laboratories.

Global Optogenetics Market: Segmentation

The global Optogenetics market is primarily segmented into product type, nature, end user, distribution channel and region. This report offers historical data points and forecasts and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2018 to 2028. The market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and market share contribution by each regional and country market. In addition, the report offers industry analysis and competitive landscape, company financials, and impact analysis.

The report includes a detailed view of the global Optogenetics market, along with changing dynamics and trends, scenarios, detailed market and regional segmentation, regional landscape, analysis and evaluation, major investments, product offerings, product launches, and details of historical, current, and projected revenues. For this study, Reports and Data has segmented the global market based on different segments as follows.

Sensor Outlook (Revenue, USD Billion; 2018 – 2028)

  • Genetically Modified Calcium Indicators
  • pH Sensors
  • Neurotransmitter Release
  • Voltage-sensitive Fluorescent Proteins

Technique Outlook (Revenue, USD Billion; 2018 – 2028)

  • Channelrhodopsin
  • Halorhodopsin
  • Archaerhodopsin

Application Outlook (Revenue, USD Billion; 2018 – 2028)

  • Retinal Disease Treatment
  • Cardiovascular Ailments
  • Neuroscience
  • Behavioral Tracking and Pacing

Light Equipment Outlook (Revenue, USD Billion; 2018 – 2028)

  • Lasers
  • LEDs
  • Others

Regional Outlook (Revenue, USD Billion; 2018 – 2028)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Benelux
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

REQUEST SAMPLE REPORT

Get Free Sample Report

REQUEST SAMPLE REPORT

REQUEST FOR CUSTOMIZATION

Tailor-make Your Research

REQUEST CUSTOMIZATION

Key questions answered by the report